期刊文献+

依达拉奉对重症脑梗死脑脊液TNF-α、IL-6的影响

Effect of Edaravone on Cerebrospinal Fluid TNF-α/IL-6 in Acute Serious Cerebral Infarction
下载PDF
导出
摘要 目的:观察依达拉奉(Edaravone,商品名必存)对重症脑梗死患者脑脊液中TNF-α、IL-6的影响,探讨必存对脑梗死的脑保护机制。方法:选择72小时内的重症脑梗死病人66例,随机分为对照组31例和治疗组35例,对照组采用常规治疗,治疗组加用必存15mg/d治疗10天,在治疗前后腰穿取脑脊液,用ELESA法检测脑脊液中TNF-α、IL-6,并在3周后进行神经功能缺损评分。结果:治疗后必存组TNF-α和IL-6的水平下降与对照组比较,具有显著统计学意义(P<0·01),治疗组对脑梗死的有效率高于对照组,具有统计学意义(χ0·052=3·96,P<0·05)。结论:必存能够通过清除自由基减轻梗死后炎症的发生,对脑梗死有脑保护作用。 Objective: To study the effect of edaravone cerebrospinal fluid TNF - α and IL- 6 with edaravone with acute serious cerebral infarction, and eveluate its protective mechanism. Methods. 66 cases of cerebral hemorrhage in 72h were randomly divided into treatment group (35 cases) and control group (31 cases), TNF- α/IL. 6 in cerebrospinal fluid were detcted by ELESA at pretherapy and after given treatment 10days. Neurological functional deficit scores were utilized for assessment before given treatment, On the 21th day after treatment, the patient was assessed again, and the efficacy was recorded. Results: After 10 days treatment, the level of TNF - α. IL - 6 more transparently fall in treatment than that of control group, there were significant difference between the two groups ( P 〈 0.01 ) ; On the 21th day after treatment, there were also significant differences between the two groups in terms of apparent effect rate (treated group: 60% ; control group. 35% ; χ0.05^2 = 3.96, P 〈 0.05). Conclusion: Edaravone alleviate inflammation via cleaning free radical, so it mayprotect brain tissue and accelerate the recovery of neural function after serious cerebral infarction.
出处 《华西医学》 CAS 2006年第4期732-733,共2页 West China Medical Journal
关键词 脑梗死 依达拉奉 TNF-Α IL-6 Edaravone cerebral infarction TNF - α IL - 6
  • 相关文献

参考文献11

  • 1Mayer TE,Hamann GF.Baranczyk J,et al.Dynamic CT perfusion imaging of acutestroke[J].AJNR,2000,21(8):1441-449.
  • 2Edaravone Acute Infarction Study Group.Effect of a novel freeradical scavenger,edaravone(MCI-186),on actue brain infarction Randomized,placebo-controlled,double-blind study at multicenters[J].Cerebmvasc Dis,2003,15:222.
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33020
  • 4Clark WM,et a1.Neurol Res,1999,21(3):28.
  • 5Suzumura A,Ito A,Yoshikowa M,et al.Zbudilast suppresses TNFalpha production by glial cells function mainly as type Ⅱ phosphodiesterast inhibitor in the CNS[J].Brain Res,1999,837(1-2):203-212.
  • 6Lavine SD,Hofan FM,Zlokovic BV.Circulation antibody against tumor necrosis factor-alpha protects rat from reperfusion injury[J].Cereb Blood Flow Metab,1998:18(1):52-58.
  • 7毕国荣,宋利春.脑梗死患者恢复期脑组织血浆肿瘤坏死因子-α、白介素-1β含量变化[J].现代康复,2001,5(6):57-58. 被引量:21
  • 8Vila N,Castillo J,Davalos A et a1.Proinflammatory cytokines and early neurological worsening in ischemic stroke[J].Stroke[J],2000,31:2325-2329.
  • 9DeGraba TJ.The role of inflammation after acute stroke:utility 0f pursuing anti-adhesion molecule theraphy[J].Neurology,1998,51(3 Suppl 3):362-368.
  • 10杨政,吴玉林.治疗急性脑梗死的新型脑保护药依达拉奉[J].中国新药杂志,2002,11(12):911-913. 被引量:352

二级参考文献14

  • 1中华神经科学会 中华神经外科学会.各类脑血管病诊断要点[J].中华神经科杂志,1996,6:379-379.
  • 2横田慎一 熊毅雄治 内海光朝.A Pharmacokinetic Study of MCI—186,a novel drug for cerebrovascular disease in elderly and young healthy subjects[J].临床药理,1997,28(3):693-702.
  • 3Mizuno A,Umemura K,Nakashima M.Inhibitory effect MCI-186,a free radical scavenger,on cerebral ischemia following rat middle cerebral artery occlusion[J].Gen Pharmacol,1998,30(4)∶575-578.
  • 4Kawai H,Nakai H,Misao S,et al.Effects of a novel free radical scavenger,MCI-186,on ischemic brain damage in the rat distal middle cerebral artery occlusion model[J].J Pharmacol Exp Ther,1997,281(2)∶921-927.
  • 5Tabrizchi R.Edaravone Mitsubishi-Tokyo[J].Curr Opin Investig Drugs,2000,1(3)∶347-454.
  • 6Yamamoto T,Yuki S,Watanabe T,et al.Delayed neuronal death prevented by inhibition of increased hydroxyl radical formation in a transient cerebral ischemia[J].Brain Res,1997,762(12)∶240-242.
  • 7Watanabe T,Egawa M.Effects of an antistroke agent MCI-186 on cerebral arachidonate cascades[J].J Pharmacol Exp Ther,1994,271(3)∶1624-1629.
  • 8Watanabe T,Morita I,Nishi H,et al.Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro[J].Prostaglandins Leukotrienes Essent Fatty Acids,1998,33(1)∶81-87.
  • 9Mitsumori K,Sakuragi M,Kitami K,et al.The effect MCI-186 on regional cerebral blood flow in patients with acute cerebral infarction-A sequential SPECT study[J].Ther Res,1998,19(4)∶1333-1345.
  • 10山本美奈子 高松康雄.Pharmacokinetic studies of 3—methyl—1—phenyl—2—pyrazolin—5—one(MCI—186):protein binding and distribution to red blood cell[J].药理と治疗,1997,25(17):1755-1763.

共引文献33277

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部